Approval · Notice of Compliance 5652 · 2004
SABRIL: Notice of Compliance 5652
Issued October 20, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5652
- Date
- October 20, 2004
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-epileptic
Products in this notice
Medicinal ingredients
- VIGABATRIN 500 MG per PCK
- VIGABATRIN 500 MG per TAB